Home » Topics » BioWorld Science

BioWorld Science
RSS

Genocea eyes IND filing for neoantigen cell therapy GEN-011

May 13, 2020

Blade Therapeutics begins phase II study of BLD-2660 in hospitalized patients with COVID-19

May 13, 2020

New biomarker identified for the aging brain

May 13, 2020

C4X Discovery Holdings presents NFE2-related factor 2 activators

May 13, 2020

New anthelmintic compounds patented by Bayer

May 13, 2020

Enabling P-TEFb-dependent transcription of Myc in heart restores cardiomyocyte proliferation

May 13, 2020

Myelopro Diagnostics & Research presents new compounds binding to calreticulin

May 13, 2020

Step Pharma identifies new CTP synthase 1 inhibitors

May 13, 2020

NTRK1 inhibitors discovered at Medshine Discovery

May 13, 2020

miR-802 overexpression links obesity with impaired insulin transcription and secretion

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...